If you are a gastroenterologist, registered dietitian, primary care physician, or other healthcare provider working with patients who have IBS or functional gastrointestinal disorders, you are already familiar with a particular kind of clinical impasse.
The patient whose colonoscopy is clear but who is no better — and often worse. The patient whose FODMAP adherence is excellent but whose symptoms remain unpredictable. The patient who is medically optimized but whose quality of life is significantly impaired by anxiety, avoidance, and the psychological weight of living with a condition that nobody seems to be fully addressing. The patient who keeps coming back, not because the medical management is inadequate, but because something outside the medical lane is driving the bus.
GI psychotherapy — gut-brain behavioral treatment for disorders of gut-brain interaction — addresses the layer of IBS that pharmacological and dietary interventions cannot reach on their own. This post is a practical guide to identifying patients who would benefit from a referral, understanding what the referral involves, and working collaboratively if that is something you are interested in.
The Evidence Base: Why This Referral Is Clinically Warranted
Before the referral conversation, it helps to have the outcomes data in hand.
Gut-directed CBT — cognitive behavioral therapy adapted specifically for IBS — has been studied in large randomized controlled trials. Lackner and colleagues (2018) found that over 60 percent of participants experienced clinically significant symptom improvement, with gains maintained at 12-month follow-up (Lackner et al., 2019). These are not modest effect sizes. They are comparable to or exceed the response rates seen with pharmacological treatment of IBS.
Gut-directed hypnotherapy has an evidence base stretching back to Whorwell’s original 1984 Lancet publication and has been the subject of dozens of trials since. A 2025 systematic review covering twelve studies found gut-directed hypnotherapy superior to comparison treatments in every single trial reviewed (Adler et al., 2025). Five-year follow-up data show that 81 percent of responders maintain their improvement without ongoing sessions (Gonsalkorale et al., 2003).
Mindfulness-Based Stress Reduction has consistent randomized trial evidence for IBS symptom reduction and quality of life improvement (Altobelli et al., 2022).
The Rome Foundation — the international body setting clinical and research standards for disorders of gut-brain interaction — identifies psychological interventions as evidence-based treatment for IBS. This is not complementary or alternative medicine. It is mainstream, guideline-supported intervention on a well-characterized mechanism: dysregulated gut-brain communication.
Who to Refer: Clinical Indicators
Not every patient with IBS needs GI psychotherapy. But a significant proportion — likely more than currently receive it — would benefit meaningfully. The following indicators are worth noting in your assessment.
Psychological Comorbidity Alongside Gut Symptoms
Anxiety disorders, depression, and IBS co-occur at rates significantly higher than chance. A systematic review and meta-analysis found anxiety disorders present in approximately 20 percent of IBS patients, with depression similarly elevated (Fond et al., 2014). When psychological comorbidity is present, treating the gut in isolation leaves a significant driver of symptoms unaddressed.
Patients who describe their gut symptoms as reliably worse during periods of emotional stress, interpersonal conflict, or psychological pressure — or who report that the anxiety about their gut has become as disruptive as the gut symptoms themselves — are strong referral candidates.
Inadequate Response to Standard Treatment
A patient who has tried dietary modification, appropriate pharmacotherapy, and standard GI management with persistent significant symptoms is the classic candidate for gut-brain behavioral treatment. The Rome Foundation guidelines specifically recommend psychological treatment for patients who do not respond to first-line interventions.
If your patient has done the FODMAP protocol correctly with RD support, is medically optimized, and is still significantly symptomatic — the nervous system layer has not been addressed.
Significant Behavioral Avoidance and Life Restriction
IBS avoidance is clinically significant and frequently underassessed in standard GI encounters. Ask your patient directly: have they stopped travelling? Do they avoid restaurants, social events, or situations away from a familiar bathroom? Have they declined work opportunities, altered their social life, or limited their diet to a narrow range of safe foods?
Avoidance maintains and amplifies IBS anxiety through a well-characterized psychological mechanism — every avoided situation provides short-term relief that reinforces the belief that the situation was dangerous, making the next avoidance more likely. Avoidance is not a secondary concern. It is a driver of chronicity, and it requires behavioral treatment to address.
History of Adverse Childhood Experiences or Trauma
Research consistently identifies early life adversity as a significant risk factor for IBS onset and severity. IBS heritability is only approximately 5.8 percent (Mayer et al., 2023), meaning environmental factors — including early relational stress, adverse childhood experiences, and chronic psychosocial strain — are far more influential than genetics in determining who develops IBS and how severely.
Patients who disclose trauma history, early adversity, or significant relational stress in the context of their IBS presentation are candidates for gut-brain therapy that includes somatic and trauma-informed approaches alongside symptom-focused protocols.
Disordered Relationship With Food Beyond FODMAP
Some patients restrict so broadly — eliminating foods based on fear rather than evidence, reducing their diet to a handful of “safe” items — that nutritional adequacy and quality of life are significantly impaired. This food anxiety often has a nervous system component that dietary counseling alone cannot address. The patient who intellectually understands that a food is low-FODMAP but cannot eat it because of fear is experiencing something more than a dietary trigger issue.
Similarly, patients who skip meals, restrict eating in social contexts, or avoid eating away from home due to gut anxiety are demonstrating behavioral patterns that lie in the gut-brain therapy domain rather than the dietetics domain alone.
The Patient Who “Just Doesn’t Get Better”
Sometimes the clearest indicator is this: a patient who is doing everything right — medically, dietetically, in terms of self-management — and who keeps coming back. Not because they are non-compliant or difficult. Because the nervous system layer is driving their symptoms and it has not been treated.
These patients often carry a significant burden of unaddressed psychological distress around their IBS: shame about their body, grief about lost quality of life, exhaustion from years of management, and a quiet hopelessness about whether things can really change. They are often the patients who respond most powerfully to gut-brain therapy, because they have been waiting for someone to address the layer nobody else has addressed.
How the Referral Conversation Can Go
Many patients are initially resistant to a psychological referral for a physical condition — particularly if previous providers have suggested it in ways that felt dismissive, as if the referral implied the symptoms were “all in their head.”
The framing matters enormously. The most effective referral conversations position gut-brain therapy as an addition to their care, not a redirection away from it — and as a treatment that works on a specific biological mechanism, not a suggestion that their experience is primarily psychological.
A useful script:
“Everything we have done is appropriate for what we can see and treat medically. I also want to make sure we are addressing the gut-brain piece — the nervous system communication that drives a significant part of what makes IBS so disruptive. There is a specific type of therapy, called GI psychotherapy, that works directly on that mechanism and has very strong evidence behind it. I would like to refer you to someone who specializes in exactly this. It is not instead of what we are doing — it is the piece that can change what we cannot reach with medication and diet alone.”
Patients who have felt dismissed by previous “it is just stress” conversations often respond very differently when the referral is framed in terms of a specific biological mechanism and a specific evidence-based treatment rather than as a suggestion to manage their emotions better.
Collaborative and Integrative Working: What This Can Look Like
GI psychotherapy works best when it is part of a coordinated care approach. I welcome collaborative relationships with referring providers at whatever level of engagement is useful.
Minimal Coordination
At the most basic level, a referral with a brief intake summary — diagnosis, current treatments, key clinical concerns — gives me the context I need to work effectively with your patient. I do not require ongoing communication if that is not practical, though I am always available to answer questions about the gut-brain approach or discuss a specific patient’s presentation.
Shared Care Communication
For patients with complex presentations, brief written updates between providers — particularly at the beginning and end of a course of treatment — help ensure that dietary and behavioral interventions are aligned. This is particularly important during FODMAP reintroduction, where the graduated exposure work of CBT and the dietary expansion work of the RD need to be coordinated rather than inadvertently working against each other.
If a patient is on medication affecting gut motility or visceral sensitivity, knowing about changes helps me understand shifts in symptom presentation during therapy.
Active Collaboration
For providers who are interested, I am glad to work more closely — sharing formulations, discussing treatment planning, or participating in brief case consultations. I have particular interest in collaborative relationships with gastroenterologists and registered dietitians who want to offer genuinely integrated IBS care to their patients, addressing the biological, dietary, and nervous system layers simultaneously.
I am also available to provide educational information about gut-brain therapy to your practice staff, or to give a brief presentation to your team about the GI psychotherapy evidence base and referral criteria if that would be useful.
What Your Patient Can Expect
Patients referred to gut-brain therapy often want to know from their primary provider what they are going into. A brief, accurate summary helps.
They can expect an initial assessment session in which their full IBS history — symptoms, triggers, timeline, previous treatments, psychological and relational context — is understood in depth. They can expect a collaborative discussion of treatment approach and realistic outcomes before work begins.
Depending on their presentation, treatment will likely involve gut-directed CBT, gut-directed hypnotherapy, or a combination of approaches alongside somatic nervous system work where appropriate. Sessions are typically fifty to sixty minutes. A full course of treatment is usually twelve to twenty sessions over three to six months, with most patients beginning to notice meaningful change within the first six to eight weeks.
Outcomes are among the strongest available for IBS. Over 60 percent of patients completing gut-directed CBT experience clinically significant improvement maintained at 12 months (Lackner et al., 2018). Eighty-one percent of hypnotherapy responders maintain their gains at five-year follow-up (Gonsalkorale et al., 2003). These are not placebo-level effects. They are durable, meaningful changes in gut function, psychological distress, and quality of life.
